That the Parliament recognises that Cold Contact Urticaria (CCU) can be a chronic condition and lead to a substantial deterioration in patients’ quality of life, affecting both their physical and mental health and wellbeing; understands that CCU is characterised by the development of wheals and/or angioedema, which can form within minutes after cold contact or exposure to a temperature that is different or lower than that of the person who has the condition, with extensive cold contact of large areas of skin sometimes leading to systemic reactions such as generalised urticaria, dyspnoea, tachycardia, hypotension and loss of consciousness; notes the calls to address the challenges identified by the new UK Rare Diseases Framework, published in early 2021, namely, to prioritise faster diagnosis, increase awareness of rare diseases, improve coordination of care, and improve access to specialist care, treatments and drugs; considers that a lack of awareness of CCU can lead to insufficient support being available to those affected, including people in the West Scotland region; notes the calls for awareness campaigns to inform health professionals and the general public on the condition and support available to people with rare diseases, and recognises the importance of integrated care and better coordination of services so that patients with this rare disease do not have to repeat complex details of their medical histories over and over again.